IP Library Granted Patent US 7,709,643
Granted Patent B2
US 7,709,643 · App. 11/813,657 · Granted May 4, 2010

Synthesis of sodium narcistatin and related compounds

Assignee: Arizona Board of Regents, a body corporate of the State of Arizona, Acting for and on Behalf of the Arizona State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,643
App. No.
11/813,657
Granted
May 4, 2010
Kind
B2
Abstract

The present invention involves use of the compounds narciclasine (2a) and 7-deoxy-narciclasine (2c), which are obtained via isolation from the medicinal plant species Narcissus (Amaryllidaceae), as precursors in a novel synthesis method in which each of these compounds are selectively hydrogenated to produce trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c). Also described herein is a novel synthesis method for producing sodium narcistatin (11) from narciclasine (2a). Further described herein are certain novel 3,4-cyclic phosphate prodrugs, including sodium-7-deoxynarcistatin (8), sodium-7-deoxy-transdihydronarcistatin (9), and sodium transdihydronarcistatin (10).

Claims (30)

1. A compound having the following structure:

2. A compound having the following structure:

3. A compound having the following structure:

4. A method for synthesizing trans-dihydronarciclasine, comprising the following steps:

a) reacting narciclasine in acetic anhydride and pyridine to produce 2,3,4,7-O-tetraacetoxy-narciclasine;

b) reacting the 2,3,4,7-O-tetraacetoxy-narciclasine with glacial acetic acid and palladium catalyst;

c) filtering the product of step b) to produce a filtrate comprising 2,3,4,7-O-tetraacetoxy-trans-dihydronarciclasine and 2,3,4,7-O-tetraacetoxy-cis-dihydronarciclasine;

d) drying the filtrate;

e) purify the filtrate via column chromatography;

f) dissolve the 2,3,4,7-O-tetraacetoxy-trans-dihydronarciclasine obtained from step e) in methanol and water and add potassium carbonate to product a reaction mixture;

g) concentrate the reaction mixture of step f) and purify via column chromatography, thereby obtaining trans-dihydronarciclasine.

5. A method for synthesizing trans-dihydronarciclasine, comprising the following steps:

a) reacting narciclasine in acetic anhydride and pyridine to produce 2,3,4,7-O-tetraacetoxy-narciclasine;

b) reacting the 2,3,4,7-O-tetraacetoxy-narciclasine in a mixture of ethanol/dichloromethane and palladium catalyst;

c) filtering the product of step b) to produce a filtrate comprising 2,3,4,7-O-tetraacetoxy-trans-dihydronarciclasine and 2,3,4,7-O-tetraacetoxy-cis-dihydronarciclasine;

d) drying the filtrate;

e) purify the filtrate via column chromatography;

f) dissolve the 2,3,4,7-O-tetraacetoxy-trans-dihydronarciclasine obtained from step e) in methanol and water and add potassium carbonate to product a reaction mixture;

g) concentrate the reaction mixture of step f) and purify via column chromatography, thereby obtaining trans-dihydronarciclasine.

6. A method for synthesizing 7-deoxy-trans-dihydronarciclasine, comprising the following steps:

a) react 7-deoxynarciclasine and TsOH in DMF and 2′,2′dimethoxypropane to form a first reaction mixture;

b) stir the first reaction mixture;

c) pour the first reaction solution into water and ethyl acetate to produce an organic phase and an aqueous phase;

d) dry, filter, then concentrate the organic phase to produce 3,4-isopropyl idene-7-deoxy-narciclasine;

e) react the 3,4-isopropylidene-7-deoxy-narciclasine with imidazole, and remove the DMF, thus producing 2-[tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropyl idene-7-deoxy-narciclasine;

f) react the 2-[tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropylidene-7-deoxy-narciclasine in ethanol and dichloromethane with a palladium catalyst to form a second reaction mixture;

g) stir the second reaction mixture, then pass the second reaction mixture through a silica gel column and elute with ethyl acetate to form a filtrate;

h) remove the solvent from the filtrate to form a first solid;

i) separate the first solid into its components using hexane/ethyl acetate in column chromatography, to yield (1) 2-[tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropylidene-7-deoxy-trans-dihydronarciclasine, (2) 2-[tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropylidene-7-deoxy-cis-dihydronarciclasine, and (3) 2-(tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropylidene-7-deoxy-iso-dihydronarciclasine;

j) react the 2-[tert-Butyl-1,1-dimethylsilyl]oxy-3,4-isopropylidene-7-deoxy-trans-dihydronarciclasine in tetrahydrofuran and formic acid with heating, to produce 7-deoxy-transdihydronarciclasine.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 5, 2018
From: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
To: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
Reel/Frame 047681/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2008
From: PETTIT, GEORGE R.; MELODY, NOELEEN
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 021578/0331 →
Continuity (2)
Provisional Application 6064439700 · Jan 14, 2005
Related Publication 20090131672A1 · May 21, 2009